HINDERING CA19-9 Rapid Test

Short Description:

The CA19-9 Rapid Test (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of CA 19-9 in human’s whole blood, serum or plasma.

Place of Origin      China
Brand name         HINDERING

Certification         CE


Product Detail

Product Tags

Cat. No.

T005-4002

Product Description

CA19-9 Rapid Test

Specimen

WB/S/P

Format

Cassette

Kit Size

10 T

Cut-Off

40 U/mL

Status

CE



CA19-9 (carbohydrate antigen 19-9, also called cancer antigen 19-9 or sialylated Lewis(a) antigen) is a tumor marker that is used primarily in the management of pancreatic cancer. CA19-9 is an antigen defined by monoclonal antibody binding to CA19-9, the tumor surface marker Sialyl-Lewis A. CA19-9 was discovered in the serum of patients with colon cancer and pancreatic cancer in 1981. The main use of CA19-9 is to see whether a pancreatic tumor is secreting it; if that is the case, then the levels should fall when the tumor is treated, and they may rise again if the disease recurs. In people with pancreatic masses, CA19-9 can be useful in distinguishing between cancer and other diseases of the gland. Because of its rising and falling levels with treatment, CA 19-9 is used as a prognostic marker for pancreatic cancer.


  • Previous:
  • Next:
  • Leave Your Message